Literature DB >> 36271148

Shared and distinct biological circuits in effector, memory and exhausted CD8+ T cells revealed by temporal single-cell transcriptomics and epigenetics.

Josephine R Giles1,2,3, Shin Foong Ngiow1,2,3, Sasikanth Manne1,2, Amy E Baxter1,2, Omar Khan1,2, Ping Wang1,2,4, Ryan Staupe1,5, Mohamed S Abdel-Hakeem1,2,6, Hua Huang1,2,7, Divij Mathew1,2, Mark M Painter1,2, Jennifer E Wu1,2,3, Yinghui Jane Huang1,2, Rishi R Goel1,2, Patrick K Yan1,8, Giorgos C Karakousis9, Xiaowei Xu9, Tara C Mitchell10, Alexander C Huang2,3,4,11, E John Wherry12,13,14.   

Abstract

Naïve CD8+ T cells can differentiate into effector (Teff), memory (Tmem) or exhausted (Tex) T cells. These developmental pathways are associated with distinct transcriptional and epigenetic changes that endow cells with different functional capacities and therefore therapeutic potential. The molecular circuitry underlying these developmental trajectories and the extent of heterogeneity within Teff, Tmem and Tex populations remain poorly understood. Here, we used the lymphocytic choriomeningitis virus model of acute-resolving and chronic infection to address these gaps by applying longitudinal single-cell RNA-sequencing (scRNA-seq) and single-cell assay for transposase-accessible chromatin sequencing (scATAC-seq) analyses. These analyses uncovered new subsets, including a subpopulation of Tex cells expressing natural killer cell-associated genes that is dependent on the transcription factor Zeb2, as well as multiple distinct TCF-1+ stem/progenitor-like subsets in acute and chronic infection. These data also revealed insights into the reshaping of Tex subsets following programmed death 1 (PD-1) pathway blockade and identified a key role for the cell stress regulator, Btg1, in establishing the Tex population. Finally, these results highlighted how the same biological circuits such as cytotoxicity or stem/progenitor pathways can be used by CD8+ T cell subsets with highly divergent underlying chromatin landscapes generated during different infections.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Year:  2022        PMID: 36271148     DOI: 10.1038/s41590-022-01338-4

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   31.250


  55 in total

1.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor.

Authors:  Nikhil S Joshi; Weiguo Cui; Anmol Chandele; Heung Kyu Lee; David R Urso; James Hagman; Laurent Gapin; Susan M Kaech
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

2.  Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade.

Authors:  Shawn D Blackburn; Haina Shin; Gordon J Freeman; E John Wherry
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

Review 3.  CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer.

Authors:  Laura M McLane; Mohamed S Abdel-Hakeem; E John Wherry
Journal:  Annu Rev Immunol       Date:  2019-01-24       Impact factor: 28.527

4.  Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection.

Authors:  William H Hudson; Julia Gensheimer; Masao Hashimoto; Andreas Wieland; Rajesh M Valanparambil; Peng Li; Jian-Xin Lin; Bogumila T Konieczny; Se Jin Im; Gordon J Freeman; Warren J Leonard; Haydn T Kissick; Rafi Ahmed
Journal:  Immunity       Date:  2019-12-03       Impact factor: 31.745

5.  T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections.

Authors:  Daniel T Utzschneider; Mélanie Charmoy; Vijaykumar Chennupati; Laurène Pousse; Daniela Pais Ferreira; Sandra Calderon-Copete; Maxime Danilo; Francesca Alfei; Maike Hofmann; Dominik Wieland; Sylvain Pradervand; Robert Thimme; Dietmar Zehn; Werner Held
Journal:  Immunity       Date:  2016-08-16       Impact factor: 31.745

6.  Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.

Authors:  Se Jin Im; Masao Hashimoto; Michael Y Gerner; Junghwa Lee; Haydn T Kissick; Matheus C Burger; Qiang Shan; J Scott Hale; Judong Lee; Tahseen H Nasti; Arlene H Sharpe; Gordon J Freeman; Ronald N Germain; Helder I Nakaya; Hai-Hui Xue; Rafi Ahmed
Journal:  Nature       Date:  2016-08-02       Impact factor: 49.962

7.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

Authors:  Susan M Kaech; Joyce T Tan; E John Wherry; Bogumila T Konieczny; Charles D Surh; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-11-16       Impact factor: 25.606

8.  Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer.

Authors:  Sri Krishna; Frank J Lowery; Amy R Copeland; Erol Bahadiroglu; Ratnadeep Mukherjee; Li Jia; James T Anibal; Abraham Sachs; Serifat O Adebola; Devikala Gurusamy; Zhiya Yu; Victoria Hill; Jared J Gartner; Yong F Li; Maria Parkhurst; Biman Paria; Pia Kvistborg; Michael C Kelly; Stephanie L Goff; Grégoire Altan-Bonnet; Paul F Robbins; Steven A Rosenberg
Journal:  Science       Date:  2020-12-11       Impact factor: 47.728

Review 9.  Defining Memory CD8 T Cell.

Authors:  Matthew D Martin; Vladimir P Badovinac
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

10.  The architectural design of CD8+ T cell responses in acute and chronic infection: Parallel structures with divergent fates.

Authors:  H Kay Chung; Bryan McDonald; Susan M Kaech
Journal:  J Exp Med       Date:  2021-04-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.